3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Leukemia
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Adenocarcinoma Of Esophagus
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Multiple Myeloma
1
Liposarcoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Cytarabine
23
fludarabine phosphate
9
Daunorubicin
9
Mitoxantrone
8
Busulfan
8
Peripheral Blood Stem Cell Transplantation
6
Methotrexate
6
Idarubicin
6
Gemtuzumab
6
Etoposide
6
Whole-Body Irradiation
5
Filgrastim
5
Cyclophosphamide
5
Clofarabine
5
tipifarnib
4
alvocidib
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Azacitidine
4
Antilymphocyte Serum
4
sargramostim
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Bortezomib
3
fludarabine
2
aldesleukin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Erythroblastic, Acute
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
No trials found.